Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RASBURICASE Cause Dyspnoea? 21 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Dyspnoea have been filed in association with RASBURICASE (Elitek). This represents 2.4% of all adverse event reports for RASBURICASE.

21
Reports of Dyspnoea with RASBURICASE
2.4%
of all RASBURICASE reports
7
Deaths
10
Hospitalizations

How Dangerous Is Dyspnoea From RASBURICASE?

Of the 21 reports, 7 (33.3%) resulted in death, 10 (47.6%) required hospitalization, and 8 (38.1%) were considered life-threatening.

Is Dyspnoea Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RASBURICASE. However, 21 reports have been filed with the FAERS database.

What Other Side Effects Does RASBURICASE Cause?

Tumour lysis syndrome (116) Methaemoglobinaemia (92) Off label use (90) Product use in unapproved indication (76) Bacterial infection (75) Fungal infection (73) Cellulitis (72) Clostridium difficile colitis (72) Lymphoid tissue hypoplasia (72) Lymphopenia (72)

What Other Drugs Cause Dyspnoea?

ALBUTEROL (21,856) TREPROSTINIL (16,348) AMBRISENTAN (13,367) PREDNISONE (12,830) BUDESONIDE\FORMOTEROL (11,158) TIOTROPIUM (10,863) ADALIMUMAB (10,547) DUPILUMAB (10,310) FLUTICASONE\SALMETEROL (9,783) MEPOLIZUMAB (9,192)

Which RASBURICASE Alternatives Have Lower Dyspnoea Risk?

RASBURICASE vs RAVULIZUMAB RASBURICASE vs RAVULIZUMAB-CWVZ RASBURICASE vs REBAMIPIDE RASBURICASE vs REBETOL RASBURICASE vs REBIF

Related Pages

RASBURICASE Full Profile All Dyspnoea Reports All Drugs Causing Dyspnoea RASBURICASE Demographics